Home > Insider Trading > Filing (0001209191-18-032789)

Filing Details

Accession Number:: 0001209191-18-032789
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-23 20:46:07
Reporting Period:: 2018-05-21

Accepted Time:: 2018-05-23 20:46:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1560241	G1 Therapeutics Inc.	GTHX	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1208570	Jr B Kenneth Lee	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1219890	Alexander Robert Ingram	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1291262	Md Douglas Reed	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1592380	Clay Thorp	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1674107	John Crumpler	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1675232	Hatteras Venture Partners Iv Sbic, Lp	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No
1675236	Hatteras Venture Advisors Iv Sbic, Llc	C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-05-21	29,005	$51.16	4,046,206	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2018-05-21	1,595	$51.06	4,044,611	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2018-05-21	474	$52.13	4,044,137	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2018-05-21	26	$52.13	4,044,111	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2018-05-22	5,592	$50.86	4,038,519	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2018-05-22	308	$50.69	4,038,211	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2018-05-23	474	$50.50	4,037,737	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2018-05-23	26	$50.50	4,037,711	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Footnotes

The price represents the weighted average price with a low of $51.00 and a high of $51.755. The Reporting Persons undertake to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
Following the reported transaction, 3,832,792 shares of the reportable securities are owned directly by Hatteras Venture Partners IV SBIC, LP ("HVP IV"). Hatteras Venture Advisors IV SBIC, LLC ("HVA IV SBIC") is the general partner of HVP IV. The securities directly held by HVP IV are indirectly held by the individual managing members of HVA IV SBIC (each, a "GP Managing Member" and collectively, the "GP Managing Members"). The GP Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The GP Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each GP Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any GP Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
Following the reported transaction, 212,419 shares of the reportable securities are owned directly by Hatteras NC Fund, LP ("Hatteras NC"). Hatteras Venture Advisors IV, LLC ("HVA IV") is the general partner of Hatteras NC Fund, LP. The securities directly held by Hatteras NC are indirectly held by the individual managing members of HVA IV (each, a "HVA IV Managing Member" and collectively, the "HVA IV Managing Members"). The HVA IV Managing Members are John Crumpler, Clay Thorp, Ken Lee, Douglas Reed and Robert Ingram. The HVA IV Managing Members may share voting and dispositive power over the securities directly held by HVP IV. Each HVA IV Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any HVA IV Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
995 shares of the reportable securities are owned directly by Hatteras Venture Advisors V, LLC ("HVA V"). The securities directly held by HVA V are indirectly held by the individual managing members of HVA V (each, a "Managing Member" and collectively, the "Managing Members"). The Managing Members are John Crumpler, Clay Thorp, Christy Shaffer, Douglas Reed and Robert Ingram. The Managing Members may share voting and dispositive power over the securities directly held by HVA V. Each Managing Member disclaims beneficial ownership of these securities and this report is not an admission that any Managing Member is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his or her pecuniary interest therein.
Following the reported transaction, 210,824 shares of the reportable securities are owned directly by Hatteras NC.
The price represents the weighted average price with a low of $52.12 and a high of $52.14.
Following the reported transaction, 3,832,318 shares of the reportable securities are owned directly by HVP IV.
Following the reported transaction, 210,798 shares of the reportable securities are owned directly by Hatteras NC.
The price represents the weighted average price with a low of $50.50 and a high of $51.25.
Following the reported transaction, 3,826,726 shares of the reportable securities are owned directly by HVP IV.
Following the reported transaction, 210,490 shares of the reportable securities are owned directly by Hatteras NC.
Following the reported transaction, 3,826,252 shares of the reportable securities are owned directly by HVP IV.
Following the reported transaction, 210,464 shares of the reportable securities are owned directly by Hatteras NC.